Pharmaceutical Composition for Lowering Blood Sugar Level
    1.
    发明申请
    Pharmaceutical Composition for Lowering Blood Sugar Level 审中-公开
    用于降低血糖水平的药物组合物

    公开(公告)号:US20080004227A1

    公开(公告)日:2008-01-03

    申请号:US10591186

    申请日:2004-09-03

    摘要: An object of the invention is to provide a pharmaceutical composition and a kit therefor for the lowering of elevated blood sugar level associated with diabetes and for the prevention of the elevation of blood sugar level. The invention provides a pharmaceutical composition containing a ligand (agonist or antagonist) for a GT01 polypeptide, particularly a free fatty acid as a GT01 polypeptide-specific ligand, or a GT01 gene or the GT01 polypeptide, for treating the hyperglycemia associated with diabetes, and a kit therefor. The invention also provides a ligand specific for the GT01 polypeptide, and a screening method exerting an influence on the binding of the specific ligand to the GT01 polypeptide.

    摘要翻译: 本发明的目的是提供一种药物组合物及其用于降低与糖尿病相关的升高的血糖水平和用于预防血糖水平升高的试剂盒。 本发明提供一种药物组合物,其含有用于治疗与糖尿病相关的高血糖症的GT01多肽,特别是游离脂肪酸作为GT01多肽特异性配体或GT01基因或GT01多肽的配体(激动剂或拮抗剂),以及 一个工具包。 本发明还提供了对GT01多肽特异性的配体,以及对特异性配体与GT01多肽的结合产生影响的筛选方法。